Morrow, Jarrett D. http://orcid.org/0000-0002-5670-5865
Chase, Robert P.
Parker, Margaret M.
Glass, Kimberly
Seo, Minseok
Divo, Miguel
Owen, Caroline A.
Castaldi, Peter
DeMeo, Dawn L.
Silverman, Edwin K.
Hersh, Craig P.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K25 HL136846, P01 HL105339, R01 HL125583, R01 HL130512, P01 HL132825, R01 HL089856, R01 HL089897, P01 HL114501)
Article History
Received: 6 January 2019
Accepted: 25 March 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: Written informed consent was obtained from each subject and the study was approved by the institutional review boards at Partners Healthcare.
: Not applicable
: Drs. Morrow, Chase, Parker, Glass, Seo, and Divo declare that they have no competing interests related to this manuscript.Dr. Owen is currently an employee of Vertex Pharmaceuticals Inc., Boston, MA but has no competing interests related to this manuscript.Dr. Castaldi has received consulting fees and grant support from GSK.Dr. DeMeo has received compensation from Novartis.In the past three years, Edwin K. Silverman received honoraria from Novartis for Continuing Medical Education Seminars and grant and travel support from GlaxoSmithKline.Dr. Hersh has received consulting fees from AstraZeneca, Concert Pharmaceuticals, Mylan, and 23andMe and grant support from Boehrinher Ingelheim and Novartis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.